Prestige Wealth Management Group’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.42M | Sell |
4,518
-336
| -7% | -$343K | 0.98% | 25 |
|
|
2026
Q1 | $4.46M | Sell |
4,854
-12
| -0.2% | -$12.2K | 0.88% | 24 |
|
|
2025
Q4 | $5.23M | Buy |
4,866
+2,798
| +135% | +$2.68M | 1% | 23 |
|
|
2025
Q3 | $1.58M | Buy |
2,068
+25
| +1% | +$18.6K | 0.3% | 47 |
|
|
2025
Q2 | $1.59M | Buy |
2,043
+1,482
| +264% | +$1.15M | 0.32% | 45 |
|
|
2025
Q1 | $463K | Sell |
561
-45
| -7% | -$37.4K | 0.1% | 99 |
|
|
2024
Q4 | $468K | Buy |
606
+12
| +2% | +$9.94K | 0.1% | 102 |
|
|
2024
Q3 | $526K | Buy |
594
+55
| +10% | +$49.4K | 0.11% | 95 |
|
|
2024
Q2 | $488K | Sell |
539
-14
| -3% | -$11.2K | 0.11% | 90 |
|
|
2024
Q1 | $430K | Sell |
553
-1
| -0.2% | -$712 | 0.09% | 102 |
|
|
2023
Q4 | $323K | Sell |
554
-55
| -9% | -$32.1K | 0.07% | 111 |
|
|
2023
Q3 | $327K | Buy |
609
+2
| +0.3% | +$1.03K | 0.08% | 106 |
|
|
2023
Q2 | $285K | Sell |
607
-2,207
| -78% | -$926K | 0.07% | 124 |
|
|
2023
Q1 | $966K | Buy |
2,814
+2,221
| +375% | +$749K | 0.24% | 49 |
|
|
2022
Q4 | $217K | Sell |
593
-1,931
| -77% | -$685K | 0.06% | 131 |
|
|
2022
Q3 | $816K | Buy |
2,524
+192
| +8% | +$60.8K | 0.23% | 49 |
|
|
2022
Q2 | $756K | Sell |
2,332
-26
| -1% | -$7.8K | 0.21% | 51 |
|
|
2022
Q1 | $675K | Buy |
2,358
+1,773
| +303% | +$456K | 0.17% | 63 |
|
|
2021
Q4 | $162K | Sell |
585
-59
| -9% | -$15K | 0.04% | 157 |
|
|
2021
Q3 | $149K | Buy |
644
+164
| +34% | +$40.5K | 0.04% | 156 |
|
|
2021
Q2 | $110K | Sell |
480
-184
| -28% | -$37K | 0.03% | 177 |
|
|
2021
Q1 | $124K | Buy |
664
+27
| +4% | +$5.28K | 0.03% | 164 |
|
|
2020
Q4 | $108K | Sell |
637
-85
| -12% | -$12.7K | 0.03% | 168 |
|
|
2020
Q3 | $107K | Buy |
722
+75
| +12% | +$11.6K | 0.03% | 164 |
|
|
2020
Q2 | $106K | Buy |
647
+41
| +7% | +$6.29K | 0.04% | 145 |
|
|
2020
Q1 | $84K | Buy |
606
+275
| +83% | +$37.8K | 0.04% | 131 |
|
|
2019
Q4 | $44K | Sell |
331
-9
| -3% | -$1.04K | 0.02% | 208 |
|
|
2019
Q3 | $38K | Buy |
340
+29
| +9% | +$3.23K | 0.02% | 220 |
|
|
2019
Q2 | $34K | Hold |
311
| – | – | 0.02% | 222 |
|
|
2019
Q1 | $40K | Sell |
311
-240
| -44% | -$29.2K | 0.02% | 201 |
|
|
2018
Q4 | $64K | Buy |
+551
| New | +$61.5K | 0.05% | 171 |
|
Other funds holding LLY
Prestige Wealth Management Group's LLY Position: Q2 2026 in Review
Prestige Wealth Management Group reduced its Eli Lilly (LLY) stake by 6.9% in Q2 2026, selling an estimated $343K and leaving 4,518 shares worth $5.42M. The position accounts for 0.98% of the portfolio, ranked #25.
Prestige Wealth Management Group first reported a position in LLY in Q4 2018 and has held it in 31 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Prestige Wealth Management Group held 4,518 shares of Eli Lilly worth $5.42M as of Q2 2026.
- Prestige Wealth Management Group sold 336 Eli Lilly shares in Q2 2026, an estimated $343K.
- Eli Lilly made up 0.98% of Prestige Wealth Management Group's portfolio in Q2 2026, its #25 holding.
- Prestige Wealth Management Group first reported a position in Eli Lilly in Q4 2018 and has held it in 31 quarters since.
- 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.